Hemocue

HemoCue is a leading provider of point-of-care diagnostic solutions, enabling healthcare practitioners across clinical settings and geographies to improve patient outcomes and clinical workflows. For more than four decades we’ve been advancing what’s possible at the point of care. HemoCue offers point-of-care testing for hemoglobin, glucose and HbA1c as well as total and differential white blood cell count. HemoCue is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. For more information, visit hemocue.com. This is the official HemoCue LinkedIn page which may contain information on products not released in all markets. For reference on products and services available in specific markets, please go to your local HemoCue website found on hemocue.com. We welcome and encourage your comments and look forward to engaging with you. However, we do not endorse or approve user-generated content, content that promotes any other use of our products other than stated in the intended use, and will remove any comments or references to such off-label use and comments that are considered abusive or defamatory. The collection, storage, use, disclosure, retention, and destruction of data on this page, including any personal data, are all subject as applicable, to LinkedIn's User Agreement and Privacy Policy and to HemoCue AB Data Privacy Policy, which can be found here: https://www.hemocue.com/en/about-us/legal/hemocue-online-privacy-policy